XML 28 R16.htm IDEA: XBRL DOCUMENT v3.25.3

Stock-Based Compensation (Tables)

3 Months Ended

Sep. 30, 2025

Stock-Based Compensation [Abstract]

Schedule of Option Activity

A summary of options terminated, as well as those that vested, during the three months ended September 30, 2025 is presented below:

Options		Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (in years)
Outstanding at July 1, 2025			172,477			$	21.08				4.9
Terminated/Expired			(6,125	)			2.32				7.4
Additional vesting			-				-				-
Outstanding and vested at September 30, 2025			166,352			$	22.26				4.4

A summary of options terminated, as well as those that vested, during the three months ended September 30, 2024 is presented below: 

Options		Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (in years)
Outstanding at July 1, 2024			235,219			$	22.05				5.5
Terminated/Expired			-				-				-
Additional vesting			3,577				9.50				8.2
Outstanding and vested at September 30, 2024			238,796			$	20.96				5.3

Schedule of Warrant Activity

A summary of warrant activity during the three months ended September 30, 2025 and 2024 is presented below:

Warrants		Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (in years)
Outstanding at July 1, 2025			429,061			$	11.03				2.7
Expired			(12,500	)			72.00				-
Additional issuances			-				-				-
Outstanding at September 30, 2025			416,561			$	9.20				2.4
Outstanding at July 1, 2024			397,781			$	12.85				3.6
Expired			-				-				-
Additional issuances			-				-				-
Outstanding and vested at September 30, 2024			397,781			$	12.85				3.4

Schedule of Deferred Stock Units Activity

A summary of deferred stock units terminated/settled, as well as those that vested, during the three months ended September 30, 2025 and 2024 is presented below:

						Weighted Average
		Number of				Exercise
		Shares				Price
Outstanding July 1, 2025			190,007			$	2.84
Issued			17,172				3.05
Terminated/Settled			-				-
Outstanding September 30, 2025			207,179			$	2.86
Outstanding July 1, 2024			207,342			$	3.64
Issued			25,510				2.45
Terminated/Settled			-				-
Outstanding September 30, 2024			232,852			$	3.51

Schedule of Restricted Stock Units Activity

A summary of restricted stock units terminated, as well as those that vested, during the three months ended September 30, 2025 and 2024 is presented below:

						Weighted Average				Weighted
		Number of				Exercise				Average
		Shares				Price				Term (Yrs)
Outstanding, July 1, 2025			165,288			$	2.42				0.68
Issued			-				-				0.00
Settled			-				-				0.00
Outstanding, September 30, 2025			165,288			$	2.42				0.43
Outstanding, July 1, 2024			307,500			$	3.90				0.00
Issued			-				-				0.00
Settled			-				-				0.00
Outstanding, September 30, 2024			307,500			$	3.90				0.00

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (i)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration